Table 5 Establishment of 1st WHO International Standards for HPV antibodies by the Expert Committee on Biological Standardization in October 2022
From: WHO International Standards for antibodies to HPV6 HPV11 HPV31 HPV33 HPV45 HPV52 and HPV58
1st WHO International Standard for Human Papillomavirus (HPV) | NIBSC Product code | unitage (IU/ampoule) | unitage (IU/mL) when reconstituted as directed in 0.25 mL dH2O | Approximate number of ampoules available from NIBSC as of Oct 2022 |
|---|---|---|---|---|
Type 6 antibodies | 19/298 | 7 | 28 | 2500 |
Type 11 antibodies | 20/174 | 6 | 24 | 1000 |
Type 31 antibodies | 20/176 | 3 | 12 | 600 |
Type 33 antibodies | 19/290 | 8 | 32 | 3000 |
Type 45 antibodies | 20/178 | 2 | 8 | 700 |
Type 52 antibodies | 19/296 | 14 | 56 | 900 |
Type 58 antibodies | 19/300 | 20 | 80 | 2400 |
